The Northern New England Clinical & Translational Research (NNE-CTR) Network was established in July 2017 to augment infrastructure and expertise needed for clinical and translational research, and to support innovative studies that will ultimately improve health outcomes in our region.

The network is supported by the National Institute of General Medical Science through their Institutional Development Award (IDeA) Infrastructure for Clinical and Translational Research Program. The program supports "the development of infrastructure and other resources required for the conduct of clinical and translational research in IDeA-eligible states" such as Maine and Vermont.

The NNE-CTR is working to accomplish the following major aims:

  • Improve the infrastructure and support for clinical and translational research in Maine, New Hampshire, and Vermont
  • Increase translational and clinical research capacity and efficacy by establishing collaborative and synergistic transdisciplinary research partnerships among the NNE-CTR institutions that emphasize health problems endemic in the rural populations of northern New England, including addiction, cancer, and cardiovascular disease, as well as the barriers that compromise rural healthcare delivery
  • Establish innovative training, mentorship and professional development programs to enable clinical and translational scientists at the NNE-CTR institutions
  • Develop infrastructure to support community healthcare practices and practice-based primary care research networks, particularly in rural areas, to engage clinical, community, public health and other stakeholders in the development and conduct of research relevant to the health needs of northern New England

Multiple Principal Investigators, Clifford Rosen and Gary Stein, lead the network.

Clifford Rosen

Clifford Rosen, M.D.

Director of the Center for Clinical and Translational Research, Maine Medical Center

Gary Stein

Gary Stein, Ph.D.

Chair of the Department of Biochemistry, The University of Vermont